Cited by 411Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity

The DOI matches its Crossref record; 122 of the 126 references it cites were found in a registry or an index.

Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications

Open access

Abstract

The World Health Organization (WHO) has recognized obesity as one of the top ten threats to human health. It is estimated that the number of obese and overweight people worldwide exceeds the number of those who are undernourished. Obesity is not only a state of abnormally increased adipose tissue in the body, but also of increased release of biologically active adipokines. Adipokines released into the circulating blood, due to their specific receptors on the surface of target cells, act as classic hormones affecting the metabolism of tissues and organs. What is more, adipokines and cytokines may decrease the insulin sensitivity of tissues and induce inflammation and development of chronic complications. Certainly, it can be stated that in an era of a global obesity pandemic, adipokines may gain more and more importance as regards their use in the diagnostic evaluation and treatment of diseases. An extensive search for materials on the role of white, brown and perivascular fatty tissue and obesity-related metabolic and chronic complications was conducted online using PubMed, the Cochrane database and Embase.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21103570

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The conversion between adipocytes. Yellow arrows: white-brown-white adipocytes transdifferentiation, white-to-pink transdifferentiation, pink-to-brown transdifferentiation (🡆blue arrow: hypothesis which needs to be proved). Modified Figure 4 of [34], and Figure 2 of [35].
Figure 1 The conversion between adipocytes. Yellow arrows: white-brown-white adipocytes transdifferentiation, white-to-pink transdifferentiation, pink-to-brown transdifferentiation (🡆blue arrow: hypothesis which needs to be proved). Modified Figure 4 of [34], and Figure 2 of [35].CC BY · PubMed Central
Figure 2 The disregulation pathway of adipokines potentially leading to metabolic disorders and chronic complications in the course of obesity.
Figure 2 The disregulation pathway of adipokines potentially leading to metabolic disorders and chronic complications in the course of obesity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 126 references

Research works printed but not linked: 2

  1. Jachimowicz-Duda, O., Wąż, P., and Zorena, K. (2015, January 19–24). Interleukin-34 concentration is dependent on LDL cholesterol, HbA1c, CRP and WHR in patients with type 2 diabetes. Proceedings of the Crossroads of Lipid Metabolism and Diabetes 2015, Copenhagen, Denmark.
  2. Jachomowicz-Duda, O., Wąż, P., and Zorena, K. (2017, January 28–29). The relationship between interleukin-34 level and selected biochemical and clinical parameters in patients with type 2 diabetes. Proceedings of the Synergy Conference: “Autoimmunity in 2017-Where Are We Now?”, New York, NY, USA.

Cited by

Sorted by citations

See all 411

Metadata

Authors
Zorena, K., Jachimowicz-Duda, O., Ślęzak, D., Robakowska, M., & Mrugacz, M.
Affiliations
  • Gdańsk Medical University (PL)
  • Independent Public Specialized Health Care Center in Lębork, Department of Internal Diseases, Węgrzynowicza 13, 84-300 Lębork, Poland
  • Medical University of Białystok (PL)
Corresponding author
Zorena, Katarzyna
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-05-18
Volume
21
Issue
10
Pages
3570
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3024358488
Cited by
411
References
126
Citations by year
2026: 39 · 2025: 61 · 2024: 105 · 2023: 86 · 2022: 73 · 2021: 35 · 2020: 11
FWCI
7.46
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
adipokines, obesity, metabolic disorders, chronic complications, insulin resistance, inflammation, cytokines, adipose tissue, brown adipose tissue, perivascular adipose tissue, obesity-related comorbidities
MeSH terms
Animals, Humans, Inflammation, Metabolic Diseases, Obesity, Adipokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review